Quick Answer
Roivant Sciences Ltd. reported Net Income of -$171.98 million for fiscal year 2025.
Roivant Sciences Ltd. Net Income — Annual History
| Fiscal Year | Net Income | YoY Change |
|---|---|---|
| 2025 | -$171.98M | -104.0% |
| 2024 | $4.35B | +531.0% |
| 2023 | -$1.01B | -19.4% |
| 2022 | -$845.26M | -4.5% |
| 2021 | -$809.23M | — |
Quarterly Net Income
| Quarter Ending | Net Income | YoY | QoQ |
|---|---|---|---|
| December 31, 2025 | -$265.89M | -257.0% | -134.2% |
| September 30, 2025 | -$113.52M | +50.7% | +49.2% |
| June 30, 2025 | -$223.35M | -334.4% | -231.9% |
| December 31, 2024 | $169.38M | -96.7% | +173.6% |
| September 30, 2024 | -$230.18M | +24.4% | -341.5% |
| June 30, 2024 | $95.30M | +132.7% | -98.1% |
| December 31, 2023 | $5.10B | +1547.7% | +1774.6% |
| September 30, 2023 | -$304.33M | -4.4% | -4.3% |
- Roivant Sciences Ltd. showed a decrease of -104.0% in Net Income compared to the prior fiscal year.
- Over the 2021–2025 period, Roivant Sciences Ltd.’s net income has grown by 78.7% (from -$809.23 million to -$171.98 million).
- The most recent figure is from Roivant Sciences Ltd.’s fiscal year 2024 report (Form 10-K), filed with the SEC on May 29, 2025.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: